LGBTQ Loyalty (LFAP) 10-K 15 Apr 21 2020 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Apr. 15, 2021	Jun. 30, 2020
Cover [Abstract]
Entity Registrant Name	LGBTQ Loyalty Holdings, Inc.
Entity Central Index Key	0001510247
Document Type	10-K
Document Period End Date	Dec. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-Known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 1,083,159
Entity Common Stock, Shares Outstanding		473,098,618
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash	$ 30,312	$ 13,188
Other receivables	100,000	100,000
Other current assets	20,983	9,220
Total current assets	151,295	122,408
Property and equipment, net		1,800
Intangible assets, net	78,285	73,076
Total assets	229,580	197,284
Current liabilities:
Accounts payable	920,569	772,065
Accrued salaries and consulting fees	605,857	650,133
Accrued interest and dividends	226,108	71,212
Notes payable	127,986	82,986
Notes payable to related party	17,885	17,885
Convertible notes payable, net of debt discount	1,661,520	363,769
Derivative liability on convertible notes payable	1,930,235	1,111,879
Total liabilities	5,490,160	3,069,929
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.001 par value, 2,000,000,000 shares authorized, 263,725,234 and 169,217,460 shares issued and outstanding as of December 31, 2020 and 2019, respectively	263,725	169,217
Additional paid-in capital	7,714,704	6,035,547
Accumulated deficit	(13,239,189)	(9,077,614)
Total stockholders' equity (deficit)	(5,260,580)	(2,872,645)
Total liabilities and stockholders' equity (deficit)	229,580	197,284
Series A Preferred Stock [Member]
Stockholders' equity (deficit):
Preferred stock
Total stockholders' equity (deficit)
Series B Preferred Stock [Member]
Stockholders' equity (deficit):
Preferred stock	50	75
Total stockholders' equity (deficit)	50	75
Series C Preferred Stock [Member]
Stockholders' equity (deficit):
Preferred stock	130	130
Total stockholders' equity (deficit)	130	130
Series D Preferred Stock [Member]
Stockholders' equity (deficit):
Preferred stock
Total stockholders' equity (deficit)

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2020	Dec. 31, 2019
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	2,000,000,000	2,000,000,000
Common stock, shares issued	263,725,234	169,217,460
Common stock, shares outstanding	263,725,234	169,217,460
Series A Preferred Stock [Member]
Preferred stock, shares authorized	1	1
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock [Member]
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	50,000	75,000
Preferred stock, shares outstanding	50,000	75,000
Series C Preferred Stock [Member]
Preferred stock, shares authorized	129,559	129,559
Preferred stock, shares issued	129,559
Preferred stock, shares outstanding	129,559
Series D Preferred Stock [Member]
Preferred stock, shares authorized	400	400
Preferred stock, shares issued
Preferred stock, shares outstanding

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenue	$ 560	$ 3,337
Cost of net revenue
Gross profit	560	3,337
Operating expenses:
Personnel costs	827,201	1,499,585
Consulting fees	300,659	734,403
Legal and professional fees	490,742	733,960
Merger costs		388,675
Sales and marketing	33,432	50,147
General and administrative	137,037	288,911
Depreciation and amortization	27,592	4,499
Total operating expenses	1,816,663	3,700,180
Loss from operations	(1,816,103)	(3,696,843)
Other income (expense):
Interest expense	(2,463,310)	(1,024,179)
Other income	3,000
Change in derivative liability	167,658	(430,458)
Total other income (expense), net	(2,292,652)	(1,454,637)
Provision for income taxes
Net loss	$ (4,108,755)	$ (5,151,480)
Weighted average common shares outstanding - basic and diluted	203,791,785	210,883,281
Net loss per common share - basic and diluted	$ (0.02)	$ (0.02)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]	Series C Preferred Stock [Member]	Series D Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Deferred Compensation [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2018					$ 121,984	$ 3,242,449	$ (195,054)	$ (3,880,234)	$ (710,855)
Balance, shares at Dec. 31, 2018					121,984,192
Merger with Maxim Partners					$ 129,559	259,116			388,675
Merger with Maxim Partners, shares	1				129,558,574
Common shares issued for related party debt conversions					$ 8,600	393,034			401,634
Common shares issued for related party debt conversions, shares					8,600,298
Maxim exchange agreement			$ 130		$ (129,559)	129,429
Maxim exchange agreement, shares	(1)		129,559		(129,558,574)
Common shares issued pursuant to note conversions					$ 26,586	768,089			794,675
Common shares issued pursuant to note conversions, shares					26,586,234
Common shares issued pursuant to debenture conversion					$ 428	45,620			46,048
Common shares issued pursuant to debenture conversion, shares					427,500
Common shares issued for services performed					$ 250	7,250			7,500
Common shares issued for services performed, shares					250,000
Exercise of stock options					$ 500	4,500			5,000
Exercise of stock options, shares					500,000
Exercise of common stock warrants					$ 4,365	301,930			306,295
Exercise of common stock warrants, shares					4,365,000
Issuance of Series B dividend common shares					$ 38	3,125			3,163
Issuance of Series B dividend common shares, shares					38,287
Issuance of Series B preferred stock, net of discount		$ 125				124,875			125,000
Issuance of Series B preferred stock, net of discount, shares		125,000
Conversion of Series B preferred stock for common shares		$ (50)			$ 1,466	(1,416)
Conversion of Series B preferred stock for common shares, shares		(50,000)			1,465,949
Warrants issued to board of directors						170,734			170,734
Amortization of deferred compensation							195,054		195,054
Amortization of preferred stock discount						36,412		(36,412)
Dividends on preferred stock								(9,488)	(9,488)
Common shares issued to board of directors					$ 5,000	550,400			555,400
Common shares issued to board of directors, shares					5,000,000
Net loss								(5,151,480)	(5,151,480)
Balance at Dec. 31, 2019		$ 75	$ 130		$ 169,217	6,035,547		(9,077,614)	(2,872,645)
Balance, shares at Dec. 31, 2019		75,000	129,559		169,217,460
Exercise of stock options					$ 4,000	6,400			10,400
Exercise of stock options, shares					4,000,000
Exercise of common stock warrants					$ 4,170	121,914			126,084
Exercise of common stock warrants, shares					4,170,000
Issuance of Series B dividend common shares					$ 90	3,360			3,450
Issuance of Series B dividend common shares, shares					90,216
Conversion of Series B preferred stock for common shares		$ (25)			$ 958	(933)
Conversion of Series B preferred stock for common shares, shares		(25,000)			958,333
Amortization of preferred stock discount						45,056		(45,056)
Dividends on preferred stock								(7,764)	(7,764)
Common shares issued in connection with notes payable					$ 295	9,705			10,000
Common shares issued in connection with notes payable, shares					294,994
Common shares issued for accrued services					$ 6,662	311,338			318,000
Common shares issued for accrued services, shares					6,662,312
Common shares issued to board of directors					$ 12,942	219,452			232,394
Common shares issued to board of directors, shares					12,942,161
Warrants issued in connection with convertible debenture						328,815			328,815
Debenture conversions					$ 49,110	369,698			418,808
Debenture conversions, shares					49,110,485
Common shares issued for services and compensation					$ 16,279	264,353			280,632
Common shares issued for services and compensation, shares					16,279,273
Net loss								(4,108,755)	(4,108,755)
Balance at Dec. 31, 2020		$ 50	$ 130		$ 263,723	$ 7,714,705		$ (13,239,189)	$ (5,260,580)
Balance, shares at Dec. 31, 2020		50,000	129,559		263,725,234

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (4,108,755)	$ (5,151,480)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount and original issue discount	862,209	368,257
Change in fair value of derivative liability	(167,658)	430,458
Financing related costs - debt	1,353,874	595,248
Merger expenses		388,675
Stock-based compensation expense	213,276	786,954
Officer deferred compensation		195,054
Depreciation and amortization	27,592	4,499
Changes in operating assets and liabilities:
Other receivables		(100,000)
Other current assets	(11,763)	(8,625)
Accounts payable	148,504	520,959
Accrued salaries and consulting fees	586,157	649,647
Accrued interest and dividends	154,896	44,490
Net cash used in operating activities	(941,668)	(1,275,855)
Cash flows from investing activities:
Purchases of property and equipment		(2,000)
Investment in intangible assets	(32,800)	(77,375)
Net cash used in investing activities	(32,800)	(79,375)
Cash flows from financing activities:
Proceeds from issuance of convertible debenture agreements	856,000	1,000,000
Net proceeds from promissory note agreements	47,250	162,500
Repayments of notes payable	(5,000)	(97,514)
Proceeds from Series B preferred stock		125,000
Proceeds from exercise of warrants	93,342	137,524
Net cash provided by financing activities	991,592	1,327,510
Net increase (decrease) in cash	17,124	(27,720)
Cash at beginning of period	13,188	40,908
Cash at end of period	30,312	13,188
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Cash paid for interest	27,500	2,500
Supplemental disclosure of non-cash financing activities:
Conversion of accrued consulting fees into common shares	617,750
Conversion of convertible debenture and notes	418,809	53,553
Conversion of related party debt		393,034
Exercise of common stock warrants - derivative liability	126,084	168,771
Amortization of preferred stock discount	45,056	36,412
Exercise of options	10,400	5,000
Warrants issued in connection with debt	328,815
Dividends on preferred stock	$ 7,763	$ 9,488

Nature of Business

Nature of Business	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business	Note 1. Nature of Business Throughout this report, the terms “our,” “we,” “us,” and the “Company” refer to LGBTQ Loyalty Holdings, Inc. (formerly LifeApps Brands Inc.), including its subsidiaries. On January 25, 2019, we acquired LGBT Loyalty LLC, a New York limited liability company, with the goal of creating the first LGBTQ Loyalty Preference Index ETF (the “Index ETF”) to provide the LGBTQ community with the power to influence the allocation of capital within a financial Index ETF based upon LGBTQ consumer preferences. The Index ETF is intended to link the growing economic influence of the LGBTQ community and their allies with many of the top Fortune 500 companies that support and implement diversity, inclusion and equality policies within their organizations. The incorporation of diversity and inclusion in a company’s recruitment and human resource policies is becoming a key concern to investors as part of their growing focus on ESG allocations. Our data and analytics unequivocally reinforce that corporations that have embraced diversity and inclusion policies within their corporate culture perform at a higher level financially than their peers. This includes advancing a more invigorated workforce that attracts and retains the best talent. Innovation and agility have been identified as great benefits of diversity, and there is an increasing awareness of what has come to be known as ‘the power of difference’. On October 30, 2019, through our wholly-owned subsidiary Loyalty Preference Index, Inc. (“LPI”) and our strategically aligned partnerships with crowd sourced data and analytic providers, we launched the LGBTQ100 ESG Index which integrates LGBTQ community survey data into the methodology for a benchmark listing of the nation’s highest financially performing large-cap publicly listed corporations that our respondents believe are most committed to advancing equality. LPI is the index provider for the LGBTQ + ESG100 ETF; LGBTQ Loyalty was the Sponsor for the prospectus that was filed by the licensed Fund Adviser ProcureAM, and was approved by the Securities and Exchange Commission (“SEC”) in early January 2020. The LGBTQ + ESG100 ETF (the “Fund”) seeks to track the investment results (before fees and expenses) of the LGBTQ100 ESG Index. The Fund earns management fees based on assets under management (“AUM”) and is expected to launch in the fourth quarter of 2021 on the NASDAQ. In late 2020, LPI was renamed to Advancing Equality Preference, Inc.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies Going Concern The accompanying financial statements have been prepared in conformity with generally accepted accounting principles (“GAAP”), which contemplates our continuation as a going concern. We have incurred losses to date of $13,239,189 and have negative working capital. To date we have funded our operations through advances from a related party, issuance of convertible debt, and the sale of our common stock. We intend to raise additional funding through third party equity or debt financing. There is no certainty that funding will be available as needed. These factors raise substantial doubt about our ability to continue operating as a going concern. Our ability to continue our operations as a going concern, realize the carrying value of our assets, and discharge our liabilities in the normal course of business is dependent upon our ability to raise capital sufficient to fund our commitments and ongoing losses, and ultimately generate profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, LGBTQ Loyalty, LLC, and Advancing Equality Preference, Inc. All material inter-company transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates. Reclassifications The Company has reclassified certain previously reported amounts in its consolidated financial statements. Accordingly, prior year amounts were reclassified to conform to the current year presentation. Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company generally maintains balances in various operating accounts at financial institutions that management believes to be of high credit quality, in amounts that may exceed federally insured limits. The Company has not experienced any losses related to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. At December 31, 2020 and 2019, all of the Company’s cash and cash equivalents were held at one accredited financial institution. Financial Instruments The estimated fair values for financial instruments were determined at discrete points in time based on relevant market information. These estimates involved uncertainties and could not be determined with precision. The carrying amounts of accounts payable and accrued liabilities approximated fair value because of the short-term maturities of these instruments. The fair value of notes payable approximated to their carrying value as generally their interest rates reflected our effective annual borrowing rate. Fair Value Measurements ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange. Level 2 – Pricing inputs are other than quoted prices in active markets, but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts, or priced with models using highly observable inputs. Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights and derivative liabilities. Our financial instruments consist of cash, other current assets, accounts payables, accruals, and notes payable. The carrying values of these instruments approximate fair value because of the short-term maturities. The Company’s restricted cash is based on Level 1 inputs. The fair value of the Company’s convertible debentures and promissory notes approximates their carrying values as the underlying imputed interest rates approximates the estimated current market rate for similar instruments. The derivative is a measured as Level 3 instrument due to the various inputs which requires significant management judgment. Refer to Note 6 for detail. The following table is a summary of our financial instruments measured at fair value: Fair Value Measurements as of December 31, 2020: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,930,235 $ 1,930,235 $ - $ - $ 1,930,235 $ 1,930,235 Fair Value Measurements as of December 31, 2019: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,111,879 $ 1,111,879 $ - $ - $ 1,111,879 $ 1,111,879 Other Receivables – Related Party Other receivables represent amounts held in escrow at the Fund’s custodian. The Company expects to retrieve the funds upon commencement of the Fund’s operations. Intangibles Intangibles, which include website development costs, databases acquired, internet domain name costs, and customer lists, are being amortized over the expected useful lives which we estimate to be three to five years. In accordance with Financial Accounting Standards Board (“FASB”), Accounting Standards Codification (“ASC”) Topic 350 Intangibles – Goodwill and Other Derivative Financial Instruments The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Company’s balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has a sequencing policy regarding share settlement wherein instruments with a fixed conversion price or floor would be settled first, and interest payable in shares settle next. Thereafter, share settlement order is based on instrument issuance date – earlier dated instruments settling before later dated. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split, to have an issuance date to coincide with the event giving rise to the additional shares. The policy includes all shares issuable pursuant to debenture and preferred stock instruments as well as shares issuable under service and employment contracts and interest on short term loans. Revenue Recognition ASC Topic 606, “ Revenue from Contracts with Customers” Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: ● identify the contract with a customer; ● identify the performance obligations in the contract; ● determine the transaction price; ● allocate the transaction price to performance obligations in the contract; and ● recognize revenue as the performance obligation is satisfied. Revenue was derived primarily from the sale of sports and fitness apparel and equipment. Stock-Based Compensation The Company accounts for stock-based compensation for employees and non-employees in accordance with ASC 718, Compensation - Stock Compensation Income Taxes The provision for income taxes is determined in accordance with the provisions of ASC Topic 740, Accounting for Income Taxes ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements, uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts. For the years ended December 31, 2020 and 2019 we did not have any interest, penalties or any significant unrecognized uncertain tax positions. Earnings per Share We calculate earnings per share in accordance with ASC Topic 260 Earnings Per Share Year Ended December 31, 2020 2019 Stock options outstanding 1,800,000 5,800,000 Warrants 235,833,333 8,885,000 Shares to be issued upon conversion of notes 600,479,598 47,170,778 838,112,931 61,855,778 Recent Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740)(“ASU 2019-12”) Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable under the circumstances.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 3. Intangible Assets The Company capitalized costs pertaining to the development of the LGBTQ100 ESG Index website. The Company began amortizing upon the launch of the index, and will amortize the costs over a three-year useful life. At December 31, 2020 and 2019, intangible assets, net was $78,285 and $73,076, respectively. Amortization expense was $25,792 and $4,499, respectively, for the years ended December 31, 2020 and 2019.

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Notes Payable	Note 4. Notes Payable As of December 31, 2020 and 2019, the Company has a note payable outstanding in the amount of $2,986 and $7,986, respectively. The note is past due at December 31, 2020 and is therefore in default. The note accrues interest at a rate of 2% per annum. During the years ended December 31, 2020 and 2019, the Company repaid $5,000 and $10,014 pertaining to this note. During the year ended December 31, 2018, the Company issued notes to an investor aggregating $15,000. On March 7, 2019, the lender agreed to convert the $15,000 in loan principal into shares of our common stock at a conversion price of $0.08 per share, resulting in an issuance of 187,500 shares, The lender also agreed to waive all interest due on the loans. During the year ended December 31, 2019, the Company received $87,500 in bridge loans from a lender. As of December 31, 2019, the Company fully repaid these loans. The Company incurred $18,300 in interest expense pertaining to these notes, including $2,500 in interest paid and $15,800 in shares of our common stock to be issued. The shares were issued in 2020 and the value was included as accrued interest as of December 31, 2019. In December 2019, the Company issued a promissory note to Pride Partners LLC (“Pride”) for $75,000. The note is secured, accrues interest at a rate of 10% per annum, and matured on June 20, 2020. As of December 31, 2020, the full principal amount was outstanding and in default.

Convertible Notes Payable

Convertible Notes Payable	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Convertible Notes Payable	Note 5. Convertible Notes Payable Convertible Note In February 2019, the holder of a 2018 Note in the original principal amount of $35,000 converted the remaining $19,000 in principal and $4,255 in interest into an aggregate of 26,398,734 shares of our common stock at a conversion price of $0.0015 per share. As the result of such conversions, the 2018 Note has been repaid in full and terminated. Convertible Debenture Pride On June 4, 2019 (the “Closing Date”), we entered into and closed a Securities Purchase Agreement (the “SPA”) with Pride (or the “Purchaser” or “Pride”) pursuant to which for a purchase price of $500,000, the Purchaser purchased $550,000 in principal amount of a 10% Original Issue Discount Senior Convertible Debenture (the “Debenture”) due 15 months following the date of issuance and an 18 month common stock purchase warrant (the “Warrant”) exercisable for up to 6,250,000 shares (subject to adjustment thereunder) of our common stock. Subject to earlier conversion or redemption, the Debenture is due on June 4, 2020 (the “Maturity Date”). At any time after June 4, 2019, the Debenture is convertible, in whole or in part, into shares of common stock (the “Conversion Shares”) at the option of the holder, at any time and from time to time (subject to a 4.99% beneficial ownership limitation). If, on the Maturity Date, the outstanding principal balance of the Debenture is $50,000 or less, the Debenture, including all accrued and unpaid interest then due thereon, is automatically convertible into common stock. Subject to adjustment, the per share conversion price for the Debenture on any conversion date is the lesser of (i) $0.1069 or (ii) 85% of the lowest single trading date volume weighted average price for our Common stock during the 5 trading days prior to the conversion date. No later than the earlier of (i) 2 trading days after our receipt of a notice of conversion and (ii) the number of trading days comprising the standard settlement period after our receipt of a notice of conversion, we are required to deliver Conversion Shares which, when permitted under applicable securities laws, will be delivered free of restrictive legends and trading restrictions. In the event that we fail to deliver Conversion Shares by the applicable delivery date, the holder may rescind such conversion until such time that the Conversion Shares are received by the holder. Our failure to timely deliver Conversion Shares subjects us to the payment of liquidated damages to the holder as well as buy-in liability under circumstances where the holder is required to purchase Common Stock in the open market in satisfaction of a sale by the holder of Conversion Shares which the holder was entitled to receive. We are required to reserve and keep available from our authorized and unissued shares of Common Stock a sufficient number of shares to cover conversions of the Debenture. The number and amount of Conversion Shares issuable upon conversion is subject to adjustment in the event of stock splits and stock dividends. The Debenture also provides for full ratchet anti-dilution price adjustments under circumstances where, during the term of the Debenture, we issue Common Stock or common stock equivalents, exclusive of certain exempt issuances, at prices below the then applicable Debenture conversion price. The Debenture further provides for adjustments in the event of certain rights offerings, pro rata distributions to shareholders and fundamental transactions. The Debenture is subject to optional redemption by us, for cash, in whole or in part, upon 20 trading days prior written notice by us but only in the event, unless waived by the holder, we satisfy certain equity conditions (as such term is defined in the Debenture) during such 20 trading day period. Penalty interest is payable by us if we fail to effect an optional redemption by the applicable optional redemption date. The Debenture subjects us to negative covenants while the Debenture is outstanding. On August 27, 2019, the Company entered into Amendment No. 1 to the Securities Purchase Agreement (the “First Amendment”) with Pride. Pursuant to the terms of the Amendment, Pride agreed to purchase an additional $220,000 in principal amount of 10% Original Issue Discount Senior Convertible Debenture for $200,000 in cash proceeds. As a result of this additional investment, the Company amended the currently outstanding 10% Original Issue Discount Senior Convertible Debenture that was issued to Pride on June 4, 2019 to increase the face value of the debenture from $550,000 to $770,000. No additional warrants were included in the amended agreement. On October 14, 2019 the Company entered into Amendment No. 2 to the Securities Purchase Agreement (the “Second Amendment”) with Pride. Pursuant to the terms of Amendment. Pride agreed to purchase an additional $330,000 in principal amount of 10% Original Issue Discount Senior Convertible Debenture for $300,000 in cash proceeds. As a result of this additional investment, the Company amended the currently outstanding 10% Original Issue Discount Senior Convertible Debenture that was issued to Pride on June 4, 2019 and amended on August 27, 2019 to increase the face value of the debenture from $770,000 to $1,100,000. Pursuant to the terms of the Second Amendment, the shares of common stock underlying the additional $330,000 in principal amount of 10% Original Issue Discount Senior Convertible Debenture (the “Additional Underlying Shares”) are not subject to the registration rights agreement entered into between the parties on June 4, 2019, but the Company has granted certain demand registration rights to Pride in connection with the Additional Underlying Shares. From July to August 2019, Pride converted $21,910 in principal into 427,500 shares of our common stock. The Company recognized $18,925 of interest expense related to the write-off of discounts related to the conversion amounts. Cavalry On February 12, 2020, the Company entered into a Securities Purchase Agreement with Cavalry Fund I LP (the “Calvary Note”). Pursuant to the terms of the Calvary Note, the lender agreed to purchase from the Company, for a purchase price of $100,000, a 10% convertible note in the principal amount of $115,500. The Cavalry Note matured and became due and payable on November 11, 2020 and accrues interest at a rate of 10% per annum. The Calvary Note, plus all accrued but unpaid interest, may be prepaid at any time prior to the maturity date. The Calvary Note is convertible into shares of the Company’s common stock at any time at a conversion price (the “Conversion Price”) equal to the lower of: (i) the lowest closing price of the common stock during the preceding twenty (20) trading day period ending on the latest complete trading day prior to the issuance date of the Note (the “Closing Price”), (ii) $0.04, or (iii) 60% of the lowest traded price for the Common Stock on the principal market on which the Common Stock is then trading during the twenty (20) consecutive trading days on which at least 100 shares of Common Stock were traded including and immediately preceding the date of conversion. Upon an event of default, the holder may elect to convert at an alternate conversion price which is the lower of: (i) the closing price of the Common Stock on the Principal Market on the Trading Day immediately preceding the issue date of the Calvary Note or (ii) 60% of either the lowest traded price or the closing bid price, whichever is lower for the common stock on the principal market during any trading day in which the event of default has not been cured. The conversion price of the Note will be further adjusted by another 15% reduction, regardless of whether there is an event of default, if (A) the Common stock is no longer a reporting company pursuant to the Securities Exchange Act of 1934, as amended, (B) the Note cannot be converted into free trading shares after 181 days from the issuance date of the Note, (C) the Common Stock is chilled for deposit at DTC or becomes chilled at any point while the Note remains outstanding, (D) deposit or other additional fees are payable due to a Yield Sign, Stop Sign or other trading restrictions, or (E) if the closing price at any time falls below $0.015. The conversion price is subject to customary adjustments. The conversion price is not subject to a floor. Effective July 14, 2020, the Company and Calvary Fund I LP entered into an amendment to the Calvary Note to extend the maturity date of the note from November 11, 2020 to December 31, 2020, prohibit any conversions of the note prior to October 31, 2020, and extend the prepayment option from August 9, 2020 to December 31, 2020. Power Up On March 10, 2020, the Company entered into a Securities Purchase Agreement with Power Up Lending Group Ltd (“Power Up Note”). Pursuant to the terms of the Power Up Note, the lender agreed to purchase from the Company, for a purchase price of $75,000, a 10% convertible note in the principal amount of $85,800. The Power Up Note matures and becomes due and payable on March 10, 2021 and accrues interest at a rate of 10% per annum. The Power Up Note, plus all accrued but unpaid interest, may be prepaid at any time prior to the maturity date. The Power Up Note is convertible into shares of the Company’s common stock at any time at a conversion price (the “Conversion Price”), which shall equal the Variable Conversion Price. The “Variable Conversion Price” shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date. The conversion price is subject to customary adjustments. The conversion price is not subject to a floor. On May 26, 2020, the Company entered into a Securities Purchase Agreement with Power Up Lending Group Ltd (“Power Up May Note”). Pursuant to the terms of the Power Up May Note, the lender agreed to purchase from the Company, for a purchase price of $75,000, a 10% convertible note in the principal amount of $85,800. The Power Up May Note matures and becomes due and payable on May 26, 2021 and accrues interest at a rate of 10% per annum. The Power Up Note, plus all accrued but unpaid interest, may be prepaid at any time prior to the maturity date. The Power Up May Note is convertible into shares of the Company’s common stock at any time at a conversion price (the “Conversion Price”), which shall equal the Variable Conversion Price. The “Variable Conversion Price” shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date. The conversion price is subject to customary adjustments. The conversion price is not subject to a floor. On September 29, 2020, the Company entered into a Securities Purchase Agreement with Power Up (“Power Up September Note”). Pursuant to the terms of the Power Up September Note, the lender agreed to purchase from the Company, for a purchase price of $80,000, a 10% convertible note in the principal amount of $91,300. The Power Up September Note matures and becomes due and payable on September 29, 2021 and accrues interest at a rate of 10% per annum. The Power Up September Note, plus all accrued but unpaid interest, may be prepaid at any time prior to the maturity date. The Power Up September Note is convertible into shares of the Company’s common stock at any time at a conversion price (the “Conversion Price”), which shall equal the Variable Conversion Price. The “Variable Conversion Price” shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date. The conversion price is subject to customary adjustments. The conversion price is not subject to a floor. As of December 31, 2020, Power Up fully converted the March and May notes, consisting of $150,000 in principal and accrued interest, into an aggregate of 49,110,485 shares of common stock. Auctus On August 11, 2020, the Company entered into a Securities Purchase Agreement (the “SPA”) with Auctus Fund, LLC (“Auctus”). Pursuant to the terms of the SPA, the Purchaser agreed to purchase from the Company, for a purchase price of $132,000, a 12% Convertible Note in the principal amount of $150,000. The Note matures and becomes due and payable on August 11, 2021 and accrues interest at a rate of 12% per annum while the Note remains outstanding. The Note may be prepaid on a monthly basis commencing six months after closing. The Note is convertible into shares of the Company’s common stock at any time at a conversion price (“Conversion Price”) equal to the lesser of (i) Current Market Price and (ii) the Variable Conversion Price. The Variable Conversion Price shall mean 100% multiplied by the Market Price (representing a discount rate of 0%). Market Price means the average of the previous 5 days volume weighted average price. In connection with the Note, the Company issued two common stock purchase warrants to purchase up to an aggregate of 15,000,000 shares of common stock (separately, “Warrant A” and “Warrant B”, and together, the “Warrants” and each a “Warrant”), upon the terms and subject to the limitations and conditions set forth in the Note. As of December 31, 2020, one warrant to purchase 7,500,000 shares was issued and outstanding to Auctus. The fair value of the warrants was determined to be $45,068 and was recorded as a debt discount to the note. On October 8, 2020, the Company entered into a Securities Purchase Agreement (the “Auctus October Note”) with Auctus Fund, Pursuant to the terms of the Auctus October Note, Auctus agreed to purchase from the Company, for a purchase price of $300,000: (i) a Convertible Promissory Note in the principal amount of $300,000 (the “Auctus Note”); (ii) a common stock purchase warrant permitting Auctus to purchase up to 100,000,000 shares of the Company’s common stock at an exercise price of $0.015 per share (the “Warrant A”); and (iii) a common stock purchase warrant permitting Auctus to purchase up to 100,000,000 shares of the Company’s Common Stock at an exercise price of $0.015 per share (the “Warrant B”) and together with the Warrant A, the “Warrants”). As of December 31, 2020, two warrants to purchase an aggregate of 200,00,000 shares was issued and outstanding to Auctus. The fair value of the warrants was determined to be $1,237,906, which was recorded as origination interest and included in interest expense in the consolidated statements of operations. The Auctus October Note accrues interest at a rate of 12% per annum and matures on October 8, 2021. The Auctus October Note is convertible into shares of the Company’s Common Stock, subject to the adjustments described therein. The conversion price shall be the “Market Price” which is defined as the volume weighted average price for the Common Stock during the 5 trading day period ending on the latest complete trading day prior to the conversion date. JSJ On September 28, 2020, the Company entered into a convertible promissory note (“JSJ Note”) with JSJ Investments, Inc., pursuant to which JSJ purchased from the Company, at a purchase price of $100,000, a 10% Convertible Note in the principal amount of $108,000. The JSJ Note accrues interest at a rate of 10% per annum and matures on September 28, 2021. The JSJ Note, plus all accrued but unpaid interest and other amounts due on the JSJ Note, may be prepaid at any time prior to the maturity date. Upon an event of default, the interest rate shall increase to 18% for as long as the event of default is continuing (“Default Interest”). At any time on or after the Maturity Date, the Company may repay the then outstanding principal plus accrued interest and Default Interest, if any, to JSJ. The JSJ Note is convertible into shares of the Company’s common stock at any time after 180 days from the issuance date. The conversion price is 60% multiplied by the lowest trading price for the common stock during the 20 trading day period ending on the latest complete trading day prior to the date of a conversion notice. EMA On March 11, 2020, the Company entered into a Securities Purchase Agreement (the “EMA Note”) with EMA Financial, LLC. Pursuant to the terms of the EMA Note, EMA agreed to purchase from the Company, for a purchase price of $75,000, a 10% Convertible Note in the principal amount of $85,000. The EMA Note accrues interest at a rate of 10% per annum and matures on November 5, 2020. The EMA Note, plus all accrued but unpaid interest and other amounts due on the EMA Note, may be prepaid at any time prior to the maturity date. The EMA Note is convertible into shares of the Company’s common stock. The conversion price shall be the lower of: (i) the lowest closing price of the common stock during the preceding 20 trading day period ending on the latest complete trading day prior to March 11, 2020, (ii) $0.04, or (iii) 60% of the lowest traded price for the common stock on the principal market during the 20 consecutive trading days on which at least 100 shares of common stock were traded including and immediately preceding the conversion date. Additional discounts to the conversion price and penalties will apply if certain events occur, including if the closing price drops below $0.015, if the Company’s stock is subject to a DTC chill, or if the EMA Note cannot be converted in free trading shares after 181 days from the issuance date. Effective as of September 29, 2020, the Company and EMA entered into an Amendment to the Note (the “EMA Amendment”), pursuant to which EMA and the Company agreed to amend the issuance date of the EMA Note from March 11, 2020 to September 29, 2020 and to extend the maturity date of the EMA Note from November 5, 2020 to September 29, 2021. As of December 31, 2020, the EMA Note was in default and the parity value of the EMA Note was determined to be $615,134. As a result, the Company recorded an expense of $530,134, which is included in interest expense in the consolidated statements of operations. In connection with the EMA Note, in October 2020 the Company issued a warrant to purchase 28,333,333 shares of common stock at an exercise price of $0.015 per share. The fair value of the warrants was determined to be $99,935, which was recorded as origination interest and included in interest expense in the consolidated statements of operations. During the years ended December 31, 2020 and 2019, the Company, recorded amortization of debt discount and original discount of $862,209 and $368,257, respectively, for all convertible debentures. This amount is included in interest expense in our consolidated statements of operations. The following is a summary of the activity of the convertible notes payable and convertible debenture for the year ended December 31, 2020 and 2019: Note Debenture Total Balance as of December 31, 2018 $ 34,065 $ - $ 34,065 Issuance of convertible debenture - principal amount - 1,100,000 1,100,000 Issuance of convertible debenture - debt discount and original issue discount - (1,100,000 ) (1,100,000 ) Amortization of debt discount and original issue discount - 368,257 368,257 Conversion to common stock, net of discount (34,065 ) (4,487 ) (38,552 ) Balance as of December 31, 2019 - 363,769 363,769 Issuance of convertible debenture - principal amount - 1,021,400 1,021,400 Issuance of convertible debenture - debt discount and original issue discount - (1,021,400 ) (1,021,400 ) Amortization of debt discount and original issue discount - 862,209 862,209 Default penalty - 530,134 530,134 Conversion to common stock, net of discount - (94,593 ) (94,593 ) Balance as of December 31, 20120 $ - $ 1,661,520 $ 1,661,520 The following comprises the balance of the convertible debenture outstanding at December 31, 2020: Principal amount outstanding $ 2,458,024 Less: Unamortized original issue discount (94,857 ) Less: Unamortized debt discount (701,647 ) $ 1,661,520

Derivative Liability

Derivative Liability	12 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability	Note 6. Derivative Liability We evaluated the terms of the conversion features of the debentures and related debenture warrants as noted above in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock To determine the fair value of our embedded derivatives, management evaluates assumptions regarding the probability of certain future events. Other factors used to determine fair value include our period end stock price, historical stock volatility, risk free interest rate and derivative term. The fair value recorded for the derivative liability varies from period to period. This variability may result in the actual derivative liability for a period either above or below the estimates recorded on our consolidated financial statements, resulting in significant fluctuations in other income (expense) because of the corresponding non-cash gain or loss recorded. We value the conversion feature at origination of the notes using the Black-Scholes valuation model. We value the derivative liability at the end of each accounting period, and upon conversion of the underlying note or warrant, with the difference in value recognized as gain or loss included in other income (expense) in our consolidated statements of operations. 2018 Note In February 2019, the 2018 Note was converted into common stock and the remaining derivative liability balance of $42,104 was recorded to additional paid-in capital and change in fair value. Convertible Debentures and Warrants The Pride debentures and warrants issued in 2019, as well as the Calvary, Power Up, JSJ, EMA and Auctus debentures issued in 2020 have conversion features that resulted in derivative liabilities. We valued the conversion features at each origination date with the following assumptions, on a weighted-average basis: Year Ended December 31, 2020 Risk-free interest rate 0.14 % Expected term (in years) 0.89 Expected volatility 188.3 % Expected dividend yield 0 % Exercise price of underlying common shares $ 0.01 Year Ended December 31, 2019 Tranche 1 Tranche 2 Tranche 3 Warrants Risk-free interest rate 2.11 % 1.75 % 1.67 % 2.11 % Expected term (in years) 1.25 1.03 0.89 1.25 Expected volatility 312.4 % 303.70 % 326.88 % 312.4 % Expected dividend yield 0 % 0 % 0 % 0 % Exercise price of underlying common shares $ 0.09 $ 0.04 $ 0.04 $ 0.08 During the years ended December 31, 2020 and 2019, the entire value of the principal of the debentures were assigned to the derivative liability and recognized as a debt discount on the convertible debentures. The debt discount is recorded as reduction (contra-liability) to the debentures and are being amortized over the initial term. Any excess balance was recognized as origination interest on the derivative liability and expensed on origination. The following is a summary of the activity of the derivative liability for the years ended December 31, 2020 and 2019: Debenture Warrants Total Balance as of December 31, 2018 $ 42,104 $ - $ 42,104 Conversion of convertible notes payable to common stock (737,813 ) - (737,813 ) Initial fair value on issuance of convertible debenture 1,077,117 492,921 1,570,038 Common stock warrant exercises - (168,771 ) (168,771 ) Conversion of principal amount of debenture to common stock (24,137 ) - (24,137 ) Change in fair value of derivative liability 690,707 (260,249 ) 430,458 Balance as of December 31, 2019 1,047,977 63,902 1,111,879 Initial fair value on issuance of convertible debenture 1,265,775 - 1,265,775 Debenture conversions (247,209 ) - (247,209 ) New warrant issuances - 39,690 39,690 Common stock warrant exercises - (72,244 ) (72,244 ) Change in fair value of derivative liability (136,310 ) (31,348 ) (167,658 ) Balance as of December 31, 2020 $ 1,930,235 $ - $ 1,930,235

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Stockholders' Equity	Note 7. Stockholders’ Equity On March 26, 2019, we filed a Certificate of Amendment to our Certificate of Incorporation to increase our authorized capitalization from 500,000,000 shares of common stock, par value $0.001 per share and 10,000,000 shares of preferred stock, par value $0.001 per share, to 1,000,000,000 shares of common stock, par value $0.001 per share and 10,000,000 shares of preferred stock, par value $0.001 per share. Common Stock 2020 Transactions In January 2020, we issued 294,994 shares of common stock to a bridge noteholder in connection with promissory notes received. During the year ended December 31, 2020, we issued an aggregate of 10,052,318 shares of common stock to consultants for 2019 services which were accrued at a fair value of $459,417. In March 2020, we issued 1,000,000 shares to Orlando Reece pursuant to his appointment to the Board of Directors. In May 2020, we issued an aggregate of 11,942,161 shares to directors as compensation. In April 2020, we issued 90,216 shares and 958,333 shares of common stock to a Series B Preferred Stock investor for accrued dividends and conversion of 25,000 shares of the Series B Preferred Stock. In May 2020, we issued an aggregate of 12,889,267 shares of common stock to executives, officers and consultants for services rendered for a total fair value of $139,215. In June 2020, two option holders exercised their outstanding options for a total of 4,000,000 shares of common stock at an exercise price of $0.0026. The value of $10,400 was converted from outstanding accounts payable. During the year ended December 31, 2020, we issued an aggregate of 4,170,000 shares of common stock to Pride Partners pursuant to warrant exercises. Refer to Note 8. From September through December 2020, the Company issued 49,110,845 shares of common stock pursuant to conversion of debentures in the principal amount of $171,600. 2019 Transactions On January 25, 2019, we entered into and closed a securities exchange under a Securities Exchange Agreement (the “Securities Exchange Agreement”) with LGBT Loyalty LLC (“LGBT Loyalty”) and Maxim Partners, LLC (“Maxim”), pursuant to which we acquired all of the membership interests of LGBT Loyalty, making LGBT Loyalty a wholly owned subsidiary of ours, in exchange for 120,959,996 shares (the “Shares”) of our restricted common stock and one share of our newly created Series A Convertible Preferred Stock (the “Series A Preferred Stock”). The Shares issued to Maxim represented, upon issuance, 49.99% of our then issued and outstanding shares of common stock. On March 29, 2019 an additional 8,598,578 shares were issued to Maxim for the conversion of the Series A Convertible Preferred Stock. LGBT Loyalty has no assets, liabilities nor operations at the exchange date, therefore, the value ascribed to the issued stock ($388,675) has been charged to operations as expenses of the merger. In February 2019, we issued an aggregate of 750,000 shares of common stock to a consultant in accordance with a service contract that provided for a 250,000 stock grant for services performed of $7,500, as well as the exercise of 500,000 stock options in exchange for the cancellation of $5,000 then outstanding accounts payable due to the consultant for prior services. In March 2019, we issued an aggregate of 8,600,298 shares of our common stock pursuant to the automatic exercise of warrants issued to two current and prior company officers. The warrants were issued in exchange for the cancellation of an aggregate of $348,312 of salary and interest accruals through December 31, 2018. During the year ended December 31, 2019, we issued an aggregate of 26,586,234 shares of our common stock to two lenders pursuant to note conversions. Additionally, we issued 427,500 shares to Pride pursuant to debenture conversions. Refer to Note 5 above. During the year ended December 31, 2019, we issued an aggregate of 5,000,000 shares of common stock to five unrelated individuals in accordance with their appointment as directors of the Company. During the year ended December 31, 2019, we issued an aggregate of 4,365,000 shares of common stock to Pride pursuant to warrant exercises. Refer to Note 8. During the year ended December 31, 2019, we issued an aggregate of 38,287 shares and 1,465,949 shares of common stock to two Series B Preferred Stock investors for accrued dividends and conversion of 50,000 shares of the Series B Preferred Stock. Series B Convertible Preferred Stock On April 3, 2019 we filed a Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock with the Delaware Secretary of State to create a new class of preferred stock, $0.001 par value per share, designated Series B Convertible Preferred Stock (“Series B Preferred Stock”) and authorized the issuance of up to 1,500,000 shares of Series B Preferred Stock. The Series B Preferred Stock has no voting, liquidation or other rights other than the right to receive dividends and to convert into common stock. The stated value of each share of Series B Convertible Preferred Stock for purposes of conversions and dividends is $1.15 (the “Conversion/Dividend Stated Value”). The stated value of each share of Series B Convertible Preferred for purposes of redemptions is $1.35 (the “Redemption Stated Value”). On April 3, 2019 we received an aggregate of $125,000 from the issuance of 125,000 shares of the Series B Convertible Preferred Stock. Each $25,000 of the preferred stock is convertible into $28,750 worth of common stock. The discount between the $28,750 and $25,000 for each $25,000 investment has been recognized and amortized. Additionally, the Preferred Stock contains a Beneficial Conversion Feature (BCF) that has been recognized. The BCF is the difference between the conversion price and the market price at inception multiplied by the number of common shares into which the Preferred Stock is convertible. The BCF is also treated as a discount on the Preferred Stock, which is amortized over the life of the instrument. Amortization of the discount will continue through April 3, 2021 and amounted to $36,412 for the year ended December 31, 2019. Subject to earlier conversion or redemption, the Series B Preferred Stock will automatically convert into fully paid and non-accessible shares of our common stock 24 months following the date of issuance of such Series B Preferred Stock without any action or payment required on the part of the holder of the Series B Convertible Preferred Stock. Subject to a floor price limitation of $0.03 per share, the automatic conversion price to which the Conversion/Dividend Stated Value will be applied will be the lower of (i) $0.10 per share of common stock; or (ii) a 20% discount to the lowest volume weighted average price (“VWAP”) for our common stock on our principal trading market during the five (5) trading days immediately prior to the automatic conversion date. In April 2020, we issued 90,216 shares and 958,333 shares of common stock to a Series B Preferred Stock investor for accrued dividends and conversion of 25,000 shares of the Series B Preferred Stock. In September 2019, a Series B investor converted 25,000 shares of Series B Preferred Stock for 734,918 shares of common stock. In October 2019, a Series B investor converted 25,000 shares of Series B Preferred Stock for 731,031 shares of common stock. Additionally, we issued an aggregate of 38,287 shares for Series B dividends. As of December 31, 2020, we had $12,075 in remaining accrued Series B dividends. Series C Convertible Preferred Stock On June 3, 2019 we filed a Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock (the “Series C COD”) with the Delaware Secretary of State to create a new class of preferred stock, $0.001 par value per share, designated Series C Convertible Preferred Stock (“Series C Preferred Stock”) and authorized the issuance of up to 129,559 shares of Series C Preferred Stock. On the Closing Date, all of the 129,559 shares of Series C Preferred Stock were issued to Pride, the assignee of Maxim. On June 4, 2019 we entered into a Securities Exchange Agreement with Maxim (the “Holder”) pursuant to which the Holder exchanged 129,558,574 shares of Common Stock for 129,559 shares (the “Exchange Shares”) of our Series C Preferred Stock (the “Share Exchange”). At the request of the Holder, the Exchange Shares were issued to Holder’s assignee. The Series C Preferred Stock has no voting or other rights other than the right to receive dividends on a pari passu basis with holders of our Common Stock, the right to receive assets in the event of liquidation, dissolution or winding up on a pari passu basis with holders of our Common Stock and the right to convert into common stock. The stated value of each share of Series C Convertible Preferred for purposes of conversions is $1,000 (the “Stated Value”). Each share of Series C Preferred Stock is convertible, at any time and from time to time, at the option of the holder thereof, into that number of shares of Common Stock (subject in each case to a 4.99% beneficial ownership limitation) determined by dividing the Stated Value of such share of Series C Preferred Stock by the Series C Preferred Stock conversion price of $1.00 per share. Consequently, each Share of Series C Preferred Stock is presently convertible into 1,000 shares of Common Stock. Deferred Officer Compensation We recorded $195,054 of amortization of deferred officer compensation during the year ended December 31, 2019. As of December 31, 2019, all deferred officer compensation had been fully amortized.

Options and Warrants

Options and Warrants	12 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Options and Warrants	Note 8. Options and Warrants Options The following is a summary of stock options issued pursuant to the 2012 Equity Incentive Plan: Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in years) Intrinsic Value Outstanding as of December 31, 2018 6,300,000 $ 0.0049 2.4 $ - Granted - - - - Exercised (500,000 ) 0.01 - - Forfeited - - - - Outstanding as of December 31, 2019 5,800,000 $ 0.00 1.5 $ - Granted - - - - Exercised (4,000,000 ) 0.01 - - Forfeited - - - - Outstanding as of December 31, 2020 1,800,000 $ 0.00 0.5 $ - Exercisable as of December 31, 2020 1,800,000 $ 0.0045 0.5 $ - As of December 31, 2020 and 2019, we had 1,800,000 and 5,800,000 options, respectively, remaining outstanding pursuant to the 2012 Equity Incentive Plan. There was no stock based compensation expense for options for the years ended December 31, 2020 and 2019. There will be no additional compensation expense recognized in future periods. Warrants 2020 Transactions During the year ended December 31, 2020, Pride exercised an aggregate of 4,170,000 shares of common stock pursuant to the exercise provisions of the warrant, including a simultaneous grant and exercise of 2,285,000 warrants. As of December 31, 2020, Pride had no outstanding warrants remaining. The Company received total proceeds of $93,342 a result of the warrant exercises. In May 2020, we cancelled warrants that were issued in 2019 to board members to purchase an aggregate of 7,000,000 shares of our common stock. See Note 9. In August 2020, we issued 7,500,000 warrants to Auctus in connection with the Auctus Note. The exercise price of the Auctus Warrants is $0.15 per share. In October 2020, we issued 200,000,000 warrants in connection with the Auctus October Note with an exercise price of $0.15 per share. Furthermore, we issued 28,333,333 warrants to EMA in connection with the EMA note. The exercise price of the EMA Warrants is $0.15 per share. 2019 Transactions On January 25, 2019 we issued warrants to two Company executives in exchange for the cancellation of an aggregate of $348,312 of salary and interest accruals through December 31, 2018. The warrants were fully exercised as described in Note 7 above. On January 25, 2019 we issued warrants to two Company executives in exchange for the cancellation of an aggregate of $348,312 of salary and interest accruals through December 31, 2018. The warrants were fully exercised as described in Note 7 above. On June 4, 2019 we issued a warrant to Pride to purchase an aggregate of 6,250,000 shares of our common stock. The warrant is exercisable through December 4, 2020. The exercise price per share of common stock under this warrant shall be the lesser of (i) $0.0855, or (ii) 75% of the lowest single trading day closing price during the five trading days prior to the exercise date. During the year ended December 31, 2019, Pride exercise an aggregate of 4,365,000 shares of common stock pursuant to the exercise provisions of the warrant. The Company received total proceeds of $137,524 a result of the warrant exercises. On December 13, 2019, we issued warrants to board members to purchase an aggregate of 7,000,000 shares of our common stock. The exercise price per share of common stock is $0.03 and the warrants were exercisable immediately. The following is a summary of the warrant activity for the years ended December 31, 2020 and 2019: Warrants Weighted Average Exercise Price Outstanding as of December 31, 2018 - $ - Granted 21,850,298 0.05 Exercised (12,965,298 ) 0.05 Forfeited - - Outstanding as of December 31, 2019 8,885,000 $ 0.04 Granted 238,118,333 0.02 Exercised (4,170,000 ) 0.08 Forfeited (7,000,000 ) 0.03 Outstanding as of December 31, 2020 235,833,333 $ 0.02

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Note 9. Related Party Transactions Parties, which can be a corporation or an individual, are considered to be related if we have the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence. Notes Payable to Related Party Notes payable to related parties at December 31, 2020 and 2019 totaled $17,885 with a 2% annual interest rate. Currently the Company has defaulted on all of their related party loan obligations. Forbearance has been granted by the related parties on all loans. Accrued Salaries In March 2019, we issued an aggregate of 8,600,298 shares of our common stock pursuant to the automatic exercise of warrants issued to two current and prior company officers. The warrants were issued in exchange for the cancellation of an aggregate of $348,312 of salary and interest accruals through December 31, 2018. As of December 31, 2020 and 2019, accrued salaries to our company officers and executive director totaled $299,732 and $91,352, respectively and is included in accrued salaries and consulting fees in our consolidated balance sheets. Board of Directors In March 2020, the Company issued 1,000,000 shares to Orlando Reece pursuant to his appointment to the board, and recognized $17,800 in compensation expense. In May 2020, we issued an aggregate of 11,942,161 shares to directors as compensation, including 3,942,161 shares pursuant to accrued monthly fees and 8,000,000 shares pursuant to 2020 annual compensation. In conjunction with this transaction, we cancelled 7,000,000 warrants that were issued to the board in December 2019. We accounted for the modification in accordance with ASC 718-20-35. Total fair value of the shares issued and warrant modification was $214,595. In March and April 2019, we issued an aggregate of 5,000,000 shares of common stock to five unrelated individuals in accordance with their appointment as directors of the Company, and recognized $555,401 in compensation expense. In 2019, we began the accrual of director’s fees for five individuals at the rate of $25,000 per annum. Four of the directors have agreed to receive their fee payments in shares of the Company’s common stock with the number of shares to be issued based on the 5-day average trading price of the stock at the end of each month. Total accrued directors’ compensation of $94,584 and $80,000 at December 31, 2020 and 2019, respectively, is included in accrued salaries and consulting fees on our consolidated balance sheets. A board member is the co-founder and president of ProcureAM, LLC, the fund advisor for the Fund. As of December 31, 2020 and 2019, we have $100,000 included as other receivables on our consolidated balance sheet, which represents amounts held in escrow at the Fund’s custodian. Accounts Payable As of December 31, 2020, the Company had $18,981 included in accounts payable to related parties including officers and board members.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Note 10. Income Taxes Income tax provision (benefit) for the years ended December 31, 2020 and 2019 is summarized below: Year Ended December 31, 2020 2019 Current income tax provision: Federal $ - $ - State - - Total current income tax provision - - Deferred income tax benefit: Federal (139,793 ) (497,200 ) State (36,607 ) (130,200 ) Total deferred income tax benefit (176,400 ) (627,400 ) Change in deferred tax asset valuation allowance 176,400 627,400 Total provision for income taxes $ - $ - The provision for income taxes differs from the amount computed by applying the statutory federal income tax rate to income before provision for income taxes. The sources and tax effects of the differences as of December 31, 2020 and 2019 are as follows: Year Ended December 31, 2020 2019 Federal statutory income tax rate 21.0 % 21.0 % State income taxes, net of federal benefit 5.5 5.5 Change in deferred tax asset valuation allowance (26.5 ) (26.5 ) Effective income tax rate - % - % Components of the net deferred income tax assets at December 31, 2020 and 2019 were as follows: December 31, 2020 2019 Net operating loss carryforwards $ 1,363,000 $ 1,155,600 Depreciation and amortization (31,000 ) - Valuation allowance (1,332,000 ) (1,155,600 ) Net deferred tax assets $ - $ - December 31, 2020 2019 Valuation allowance as of beginning of year $ 1,155,600 $ 528,200 Increases recorded to income tax provision 176,400 627,400 Valuation allowance as of end of year $ 1,332,000 $ 1,155,600 In accordance with ASC 740, at December 31, 2020 we determined that a valuation allowance should be recognized against deferred tax assets because, based on the weight of available evidence, it is more likely than not (i.e., greater than 50% probability) that some portion or all of the deferred tax asset will not be realized in the future. We recognized a reserve of 100% of the amounts of the deferred tax benefit in the amount of $1,332,000. As of December 31, 2020, we had cumulative net operating loss carry forwards of approximately $6,539,000 which have varying expirations. There are open statutes of limitations for taxing authorities in federal and state jurisdictions to audit our tax returns from 2010 through the current period. Our policy is to account for income tax related interest and penalties in income tax expense in the consolidated statement of operations. There have been no income tax related interest or penalties assessed or recorded.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 11. Commitments and Contingencies Employment Agreements On December 19, 2017 we entered into an Employment Services Agreements with our Chief Executive Officer and our President and an Executive Management Consulting Agreement with our former Chief Executive Officer. The Agreements have a two-year term and are subject to automatic renewal for successive periods of one year unless either we or the counterparties give the other written notice of intention to not renew at least 30 days prior to the end of the existing term. The Agreements with our current and former Chief Executive Officers provide for base compensation of $150,000. Effective January 1, 2020, the Board approved that the Chief Executive Officer’s salary is $200,000 per year. Each of the foregoing Agreements contain customary termination provisions including terminations with or without cause, for good reason or voluntarily, non-competition and non-solicitation provisions, and an inventions and patents provision which provides that all the work produced by the counterparties, which is created, designed, conceived or developed by them in the course of their employment under the Agreements belong to us. Effective January 1, 2018, the Agreements were modified to remove the conversion right provisions. On February 15, 2019 the Executive Management Consulting Agreement with our former Chief Executive Officer was terminated by mutual agreement. Contingencies The Company may be subject to pending legal proceedings and regulatory actions in the ordinary course of business. The results of such proceedings cannot be predicted with certainty, but the Company does not anticipate that the final outcome, if any, arising out of any such matters will have a material adverse effect on its business, financial condition or results of operations.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 12. Subsequent Events On February 5, 2021, we amended our Certificate of Incorporation to increase our authorized capitalization from 1,000,000,000 shares of common stock, par value $0.001 per share, to 2,000,000,000 shares of common stock. On March 5, 2021, the Company entered into a Securities Purchase Agreement with Power Up Lending Group Ltd (“Power Up 2021 Note”). Pursuant to the terms of the Power Up 2021 Note, the lender agreed to purchase from the Company, for a purchase price of $78,500, a 10% convertible note in the principal amount of $86,350. The Power Up 2021 Note matures and becomes due and payable on March 5, 2022 and accrues interest at a rate of 10% per annum. The Power Up 2021 Note, plus all accrued but unpaid interest, may be prepaid at any time prior to the maturity date. The Power Up 2021 Note is convertible into shares of the Company’s common stock at any time at a conversion price (the “Conversion Price”), which shall equal the Variable Conversion Price. The “Variable Conversion Price” shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date. The conversion price is subject to customary adjustments. The conversion price is not subject to a floor. Through the issuance date, the Company issued an aggregate of 37,538,998 shares of common stock pursuant to conversions of Calvary and Power Up debentures. On April 8, 2021, the Company issued 400 shares of Series D Preferred Stock to GHS Investments, LLC pursuant to a Securities Purchase Agreement (“GHS Agreement”) for net proceeds of $427,600. In conjunction with the GHS Agreement, the Company issued warrants to purchase 40,000,000 shares of common stock at an exercise price of $0.001. Management has evaluated all activity and concluded that no subsequent events have occurred that would require recognition in these financial statements or disclosure in the notes to these financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Going Concern	Going Concern The accompanying financial statements have been prepared in conformity with generally accepted accounting principles (“GAAP”), which contemplates our continuation as a going concern. We have incurred losses to date of $13,141,105 and have negative working capital. To date we have funded our operations through advances from a related party, issuance of convertible debt, and the sale of our common stock. We intend to raise additional funding through third party equity or debt financing. There is no certainty that funding will be available as needed. These factors raise substantial doubt about our ability to continue operating as a going concern. Our ability to continue our operations as a going concern, realize the carrying value of our assets, and discharge our liabilities in the normal course of business is dependent upon our ability to raise capital sufficient to fund our commitments and ongoing losses, and ultimately generate profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, LGBTQ Loyalty, LLC, and Advancing Equality Preference, Inc. All material inter-company transactions and balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates.
Reclassifications	Reclassifications The Company has reclassified certain previously reported amounts in its consolidated financial statements. Accordingly, prior year amounts were reclassified to conform to the current year presentation.
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company generally maintains balances in various operating accounts at financial institutions that management believes to be of high credit quality, in amounts that may exceed federally insured limits. The Company has not experienced any losses related to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. At December 31, 2020 and 2019, all of the Company’s cash and cash equivalents were held at one accredited financial institution.
Financial Instruments	Financial Instruments The estimated fair values for financial instruments were determined at discrete points in time based on relevant market information. These estimates involved uncertainties and could not be determined with precision. The carrying amounts of accounts payable and accrued liabilities approximated fair value because of the short-term maturities of these instruments. The fair value of notes payable approximated to their carrying value as generally their interest rates reflected our effective annual borrowing rate.
Fair Value Measurements	Fair Value Measurements ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange. Level 2 – Pricing inputs are other than quoted prices in active markets, but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts, or priced with models using highly observable inputs. Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights and derivative liabilities. Our financial instruments consist of cash, other current assets, accounts payables, accruals, and notes payable. The carrying values of these instruments approximate fair value because of the short-term maturities. The Company’s restricted cash is based on Level 1 inputs. The fair value of the Company’s convertible debentures and promissory notes approximates their carrying values as the underlying imputed interest rates approximates the estimated current market rate for similar instruments. The derivative is a measured as Level 3 instrument due to the various inputs which requires significant management judgment. Refer to Note 6 for detail. The following table is a summary of our financial instruments measured at fair value: Fair Value Measurements as of December 31, 2020: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,930,235 $ 1,930,235 $ - $ - $ 1,930,235 $ 1,930,235 Fair Value Measurements as of December 31, 2019: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,111,879 $ 1,111,879 $ - $ - $ 1,111,879 $ 1,111,879
Other Receivables - Related Party	Other Receivables – Related Party Other receivables represent amounts held in escrow at the Fund’s custodian. The Company expects to retrieve the funds upon commencement of the Fund’s operations.
Intangibles	Intangibles Intangibles, which include website development costs, databases acquired, internet domain name costs, and customer lists, are being amortized over the expected useful lives which we estimate to be three to five years. In accordance with Financial Accounting Standards Board (“FASB”), Accounting Standards Codification (“ASC”) Topic 350 Intangibles – Goodwill and Other
Derivative Financial Instruments	Derivative Financial Instruments The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Company’s balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has a sequencing policy regarding share settlement wherein instruments with a fixed conversion price or floor would be settled first, and interest payable in shares settle next. Thereafter, share settlement order is based on instrument issuance date – earlier dated instruments settling before later dated. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split, to have an issuance date to coincide with the event giving rise to the additional shares. The policy includes all shares issuable pursuant to debenture and preferred stock instruments as well as shares issuable under service and employment contracts and interest on short term loans.
Revenue Recognition	Revenue Recognition ASC Topic 606, “ Revenue from Contracts with Customers” Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: ● identify the contract with a customer; ● identify the performance obligations in the contract; ● determine the transaction price; ● allocate the transaction price to performance obligations in the contract; and ● recognize revenue as the performance obligation is satisfied. Revenue was derived primarily from the sale of sports and fitness apparel and equipment.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation for employees and non-employees in accordance with ASC 718, Compensation - Stock Compensation
Income Taxes	Income Taxes The provision for income taxes is determined in accordance with the provisions of ASC Topic 740, Accounting for Income Taxes ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements, uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts. For the years ended December 31, 2020 and 2019 we did not have any interest, penalties or any significant unrecognized uncertain tax positions.
Earnings Per Share	Earnings per Share We calculate earnings per share in accordance with ASC Topic 260 Earnings Per Share Year Ended December 31, 2020 2019 Stock options outstanding 1,800,000 5,800,000 Warrants 235,833,333 8,885,000 Shares to be issued upon conversion of notes 600,479,598 47,170,778 838,112,931 61,855,778
Recent Accounting Pronouncements	Recent Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740)(“ASU 2019-12”) Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable under the circumstances.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of Financial Instruments at Fair Value	The following table is a summary of our financial instruments measured at fair value: Fair Value Measurements as of December 31, 2020: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,930,235 $ 1,930,235 $ - $ - $ 1,930,235 $ 1,930,235 Fair Value Measurements as of December 31, 2019: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,111,879 $ 1,111,879 $ - $ - $ 1,111,879 $ 1,111,879
Schedule of Antidilutive Securities Excluded from Diluted Net Loss	For the years ended December 31, 2020 and 2019, the following number of potentially dilutive shares have been excluded from diluted net loss since such inclusion would be anti-dilutive: Year Ended December 31, 2020 2019 Stock options outstanding 1,800,000 5,800,000 Warrants 235,833,333 8,885,000 Shares to be issued upon conversion of notes 600,479,598 47,170,778 838,112,931 61,855,778

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Summary of Activity of Convertible Notes Payable and Convertible Debenture	The following is a summary of the activity of the convertible notes payable and convertible debenture for the year ended December 31, 2020 and 2019: Note Debenture Total Balance as of December 31, 2018 $ 34,065 $ - $ 34,065 Issuance of convertible debenture - principal amount - 1,100,000 1,100,000 Issuance of convertible debenture - debt discount and original issue discount - (1,100,000 ) (1,100,000 ) Amortization of debt discount and original issue discount - 368,257 368,257 Conversion to common stock, net of discount (34,065 ) (4,487 ) (38,552 ) Balance as of December 31, 2019 - 363,769 363,769 Issuance of convertible debenture - principal amount - 1,021,400 1,021,400 Issuance of convertible debenture - debt discount and original issue discount - (1,021,400 ) (1,021,400 ) Amortization of debt discount and original issue discount - 862,209 862,209 Default penalty - 530,134 530,134 Conversion to common stock, net of discount - (94,593 ) (94,593 ) Balance as of December 31, 20120 $ - $ 1,661,520 $ 1,661,520
Schedule of Balance Convertible Debenture Outstanding	The following comprises the balance of the convertible debenture outstanding at December 31, 2020: Principal amount outstanding $ 2,458,024 Less: Unamortized original issue discount (94,857 ) Less: Unamortized debt discount (701,647 ) $ 1,661,520

Derivative Liability (Tables)

Derivative Liability (Tables)	12 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Conversion Feature of Derivative Liability	We valued the conversion features at each origination date with the following assumptions, on a weighted-average basis: Year Ended December 31, 2020 Risk-free interest rate 0.14 % Expected term (in years) 0.89 Expected volatility 188.3 % Expected dividend yield 0 % Exercise price of underlying common shares $ 0.01 Year Ended December 31, 2019 Tranche 1 Tranche 2 Tranche 3 Warrants Risk-free interest rate 2.11 % 1.75 % 1.67 % 2.11 % Expected term (in years) 1.25 1.03 0.89 1.25 Expected volatility 312.4 % 303.70 % 326.88 % 312.4 % Expected dividend yield 0 % 0 % 0 % 0 % Exercise price of underlying common shares $ 0.09 $ 0.04 $ 0.04 $ 0.08
Schedule of Derivative Liability Activity	The following is a summary of the activity of the derivative liability for the years ended December 31, 2020 and 2019: Debenture Warrants Total Balance as of December 31, 2018 $ 42,104 $ - $ 42,104 Conversion of convertible notes payable to common stock (737,813 ) - (737,813 ) Initial fair value on issuance of convertible debenture 1,077,117 492,921 1,570,038 Common stock warrant exercises - (168,771 ) (168,771 ) Conversion of principal amount of debenture to common stock (24,137 ) - (24,137 ) Change in fair value of derivative liability 690,707 (260,249 ) 430,458 Balance as of December 31, 2019 1,047,977 63,902 1,111,879 Initial fair value on issuance of convertible debenture 1,265,775 - 1,265,775 Debenture conversions (247,209 ) - (247,209 ) New warrant issuances - 39,690 39,690 Common stock warrant exercises - (72,244 ) (72,244 ) Change in fair value of derivative liability (136,310 ) (31,348 ) (167,658 ) Balance as of December 31, 2020 $ 1,930,235 $ - $ 1,930,235

Options and Warrants (Tables)

Options and Warrants (Tables)	12 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Schedule of Stock Options	Options The following is a summary of stock options issued pursuant to the 2012 Equity Incentive Plan: Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in years) Intrinsic Value Outstanding as of December 31, 2018 6,300,000 $ 0.0049 2.4 $ - Granted - - - - Exercised (500,000 ) 0.01 - - Forfeited - - - - Outstanding as of December 31, 2019 5,800,000 $ 0.00 1.5 $ - Granted - - - - Exercised (4,000,000 ) 0.01 - - Forfeited - - - - Outstanding as of December 31, 2020 1,800,000 $ 0.00 0.5 $ - Exercisable as of December 31, 2020 1,800,000 $ 0.0045 0.5 $ -
Summary of Warrant Activity	The following is a summary of the warrant activity for the years ended December 31, 2020 and 2019: Warrants Weighted Average Exercise Price Outstanding as of December 31, 2018 - $ - Granted 21,850,298 0.05 Exercised (12,965,298 ) 0.05 Forfeited - - Outstanding as of December 31, 2019 8,885,000 $ 0.04 Granted 238,118,333 0.02 Exercised (4,170,000 ) 0.08 Forfeited (7,000,000 ) 0.03 Outstanding as of December 31, 2020 235,833,333 $ 0.02

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of Income Tax Provision Benefit	Income tax provision (benefit) for the years ended December 31, 2020 and 2019 is summarized below: Year Ended December 31, 2020 2019 Current income tax provision: Federal $ - $ - State - - Total current income tax provision - - Deferred income tax benefit: Federal (139,793 ) (497,200 ) State (36,607 ) (130,200 ) Total deferred income tax benefit (176,400 ) (627,400 ) Change in deferred tax asset valuation allowance 176,400 627,400 Total provision for income taxes $ - $ -
Schedule of Sources and Tax Effects	The sources and tax effects of the differences as of December 31, 2020 and 2019 are as follows: Year Ended December 31, 2020 2019 Federal statutory income tax rate 21.0 % 21.0 % State income taxes, net of federal benefit 5.5 5.5 Change in deferred tax asset valuation allowance (26.5 ) (26.5 ) Effective income tax rate - % - %
Schedule of Components of Deferred Income Tax Assets	Components of the net deferred income tax assets at December 31, 2020 and 2019 were as follows: December 31, 2020 2019 Net operating loss carryforwards $ 1,363,000 $ 1,155,600 Depreciation and amortization (31,000 ) - Valuation allowance (1,332,000 ) (1,155,600 ) Net deferred tax assets $ - $ -
Schedule of Valuation Allowance	December 31, 2020 2019 Valuation allowance as of beginning of year $ 1,155,600 $ 528,200 Increases recorded to income tax provision 176,400 627,400 Valuation allowance as of end of year $ 1,332,000 $ 1,155,600

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Incurred losses	$ 13,239,189
Income tax examination likelihood description	Greater than 50% likelihood
Interest, penalties or unreconized uncertain tax positions
Minimum [Member]
Intangible assets, expected useful life	3 years
Maximum [Member]
Intangible assets, expected useful life	5 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Financial Instruments at Fair Value (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Derivative liability on convertible notes payable	$ 1,930,235	$ 1,111,879	$ 42,104
Derivative instruments at fair value	1,930,235	1,111,879
Level 1 [Member]
Derivative liability on convertible notes payable
Derivative instruments at fair value
Level 2 [Member]
Derivative liability on convertible notes payable
Derivative instruments at fair value
Level 3 [Member]
Derivative liability on convertible notes payable	1,930,235	1,111,879
Derivative instruments at fair value	$ 1,930,235	$ 1,111,879

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Diluted Net Loss (Details) - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Antidilutive securities excluded from computation of earnings per share, amount	838,112,931	61,855,778
Stock Options Outstanding [Member]
Antidilutive securities excluded from computation of earnings per share, amount	1,800,000	5,800,000
Warrants [Member]
Antidilutive securities excluded from computation of earnings per share, amount	235,833,333	8,885,000
Shares to be Issued Upon Conversion of Notes [Member]
Antidilutive securities excluded from computation of earnings per share, amount	600,479,598	47,170,778

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets, net	$ 78,285	$ 73,076
Amortization expense	$ 25,792	$ 4,499

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	Mar. 07, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Debt instrument interest rate		2.00%	2.00%
Debt principal amount		$ 2,458,024
Debt converted into shares, value		94,593	$ 38,552
Conversion price per share	$ 0.08
Investor [Member]
Debt principal amount				$ 15,000
Lender [Member]
Debt converted into shares, value	$ 15,000
Debt converted into shares	187,500
Proceeds from bridge loans			87,500
Debt instrument, interest expense			18,300
Lender [Member] | Common Stock to be Issued [Member]
Debt instrument, interest expense			15,800
Note Payable [Member]
Note payable outsanding		$ 2,986	$ 7,986
Debt instrument interest rate		2.00%	2.00%
Repaid note		$ 5,000	$ 10,014
Interest Paid [Member] | Lender [Member]
Debt instrument, interest expense			2,500
Promissory Note [Member] | Pride Partners LLC [Member]
Note payable outsanding			$ 75,000
Debt instrument interest rate			10.00%
Debt maturity date			Jun. 20, 2020

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative)	Oct. 08, 2020USD ($)shares	Sep. 29, 2020USD ($)Trading	Sep. 28, 2020USD ($)Trading	Aug. 11, 2020USD ($)shares	May 26, 2020USD ($)Trading	Mar. 11, 2020USD ($)Trading$ / sharesshares	Mar. 10, 2020USD ($)Trading	Feb. 12, 2020USD ($)Trading$ / sharesshares	Jun. 04, 2019USD ($)shares	Mar. 31, 2019shares	Feb. 28, 2019USD ($)$ / sharesshares	Aug. 31, 2019USD ($)shares	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2019USD ($)shares	Oct. 14, 2019USD ($)	Aug. 27, 2019USD ($)	Mar. 07, 2019$ / shares
Debt principal amount													$ 2,458,024	$ 2,458,024
Conversion price per share | $ / shares																		$ 0.08
Debt interest rate													2.00%	2.00%	2.00%
Debt converted into shares, value														$ 94,593	$ 38,552
Stock issued during the period convertible													$ 171,600		46,048
Stock issued during the period convertible, shares | shares													49,110,845
Number of shares of common stock | shares										8,600,298
Amortization of debt discount and original discount														862,209	$ 368,257
Pride Partners LLC [Member]
Number of shares of common stock | shares															427,500
Securities Purchase Agreement [Member] | Pride Partners LLC [Member]
Debt instrument purchase price									$ 500,000
Securities Purchase Agreement [Member] | Cavalry Fund I LP [Member]
Debt principal amount								$ 115,500
Debenture maturity date								Nov. 11, 2020
Debt interest rate								10.00%
Debt description								The lowest closing price of the common stock during the preceding twenty (20) trading day period ending on the latest complete trading day prior to the issuance date of the Note (the "Closing Price"), (ii) $0.04, or (iii) 60% of the lowest traded price for the Common Stock on the principal market on which the Common Stock is then trading during the twenty (20) consecutive trading days on which at least 100 shares of Common Stock were traded including and immediately preceding the date of conversion. Upon an event of default, the holder may elect to convert at an alternate conversion price which is the lower of: (i) the closing price of the Common Stock on the Principal Market on the Trading Day immediately preceding the issue date of the Calvary Note or (ii) 60% of either the lowest traded price or the closing bid price, whichever is lower for the common stock on the principal market during any trading day in which the event of default has not been cured. The conversion price of the Note will be further adjusted by another 15% reduction, regardless of whether there is an event of default
Purchase price								$ 100,000
Trading days | Trading								20
Consecutive trading days | Trading								20
Number of shares of common stock | shares								100
Reduction percentage								15.00%
Closing price | $ / shares								$ 0.015
Securities Purchase Agreement [Member] | Power Up Lending Group Ltd [Member]
Debt principal amount		$ 91,300			$ 85,800		$ 85,800						$ 150,000	$ 150,000
Debt converted into shares | shares														49,110,485
Debenture maturity date		Sep. 29, 2021			May 26, 2021		Mar. 10, 2021
Debt interest rate		10.00%			10.00%		10.00%
Debt description		The "Variable Conversion Price" shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date. The conversion price is subject to customary adjustments. The conversion price is not subject to a floor.			The "Variable Conversion Price" shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date.		The "Variable Conversion Price" shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date.
Purchase price		$ 80,000			$ 75,000		$ 75,000
Trading days | Trading		20			20		20
Securities Purchase Agreement [Member] | Auctus Fund LLC [Member]
Debt principal amount	$ 300,000			$ 150,000
Debt converted into shares | shares	100,000,000			15,000,000
Debenture maturity date				Aug. 11, 2021
Debt interest rate	12.00%			12.00%
Debt description				The Variable Conversion Price shall mean 100% multiplied by the Market Price (representing a discount rate of 0%). Market Price means the average of the previous 5 days volume weighted average price. In connection with the Note, the Company issued two common stock purchase warrants to purchase up to an aggregate of 15,000,000 shares of common stock (separately
Purchase price	$ 300,000			$ 132,000
Warrants to purchase | shares													7,500,000	7,500,000
Fair value of warrants														$ 45,068
Securities Purchase Agreement [Member] | EMA Financial, LLC [Member]
Debt principal amount						$ 85,000							$ 615,134	615,134
Accrued interest													$ 530,134	$ 530,134
Debenture maturity date						Nov. 5, 2020
Debt interest rate						10.00%
Debt description						The conversion price shall be the lower of: (i) the lowest closing price of the common stock during the preceding 20 trading day period ending on the latest complete trading day prior to March 11, 2020, (ii) $0.04, or (iii) 60% of the lowest traded price for the common stock on the principal market during the 20 consecutive trading days on which at least 100 shares of common stock were traded including and immediately preceding the conversion date. Additional discounts to the conversion price and penalties will apply if certain events occur, including if the closing price drops below $0.015, if the Company's stock is subject to a DTC chill, or if the EMA Note cannot be converted in free trading shares after 181 days from the issuance date.
Purchase price						$ 75,000
Trading days | Trading						20
Consecutive trading days | Trading						20
Number of shares of common stock | shares						100
Closing price | $ / shares						$ 0.015
Warrants to purchase | shares													28,333,333	28,333,333
Fair value of warrants														$ 99,935
Exercise price | $ / shares													$ 0.015	$ 0.015
Conversion price						0.60
Securities Purchase Agreement, Debentures and Registration Rights Agreement [Member] | Pride Partners LLC [Member]
Debt principal amount																$ 330,000
Debt converted into shares | shares												427,500
Debt instrument purchase price																$ 300,000
Debt interest rate																10.00%
Debt converted into shares, value												$ 21,910
Debt instrument, interest expense												$ 18,925
Securities Purchase Agreement, Debentures and Registration Rights Agreement [Member] | Pride Partners LLC [Member] | Minimum [Member]
Debt principal amount																	$ 770,000
Debt interest rate									10.00%
Securities Purchase Agreement, Debentures and Registration Rights Agreement [Member] | Pride Partners LLC [Member] | Maximum [Member]
Debt principal amount																	1,100,000
2018 Convertible Promissory Note [Member]
Original principle amount											$ 35,000
Debt principal amount											19,000
Accrued interest											$ 4,255
Debt converted into shares | shares											26,398,734
Conversion price per share | $ / shares											$ 0.0015
10% Original Issue Discount Senior Convertible Debenture [Member] | Pride Partners LLC [Member] | Minimum [Member]
Debt principal amount																	550,000
10% Original Issue Discount Senior Convertible Debenture [Member] | Pride Partners LLC [Member] | Maximum [Member]
Debt principal amount																	770,000
10% Original Issue Discount Senior Convertible Debenture [Member] | Securities Purchase Agreement [Member] | Pride Partners LLC [Member]
Debt principal amount									$ 550,000
Debenture maturity date									Jun. 4, 2020
Debt interest rate									10.00%
Debt term									15 months
Common stock purchase warrant exercisable shares | shares									6,250,000
Debt description									At any time after June 4, 2019, the Debenture is convertible, in whole or in part, into shares of common stock (the "Conversion Shares") at the option of the holder, at any time and from time to time (subject to a 4.99% beneficial ownership limitation). If, on the Maturity Date, the outstanding principal balance of the Debenture is $50,000 or less, the Debenture, including all accrued and unpaid interest then due thereon, is automatically convertible into common stock. Subject to adjustment, the per share conversion price for the Debenture on any conversion date is the lesser of (i) $0.1069 or (ii) 85% of the lowest single trading date volume weighted average price for our Common stock during the 5 trading days prior to the conversion date.
10% Original Issue Discount Senior Convertible Debenture [Member] | Securities Purchase Agreement, Debentures and Registration Rights Agreement [Member] | Pride Partners LLC [Member]
Debt principal amount																	220,000
Debt instrument purchase price																	$ 200,000
Debt interest rate																	10.00%
Two Warrants [Member] | Securities Purchase Agreement [Member] | Auctus Fund LLC [Member]
Warrants to purchase | shares													20,000,000	20,000,000
Fair value of warrants														$ 1,237,906
Exercise price | $ / shares													$ 0.015	$ 0.015
Convertible Promissory Note [Member] | JSJ Investments, Inc [Member]
Debt principal amount			$ 108,000
Debenture maturity date			Sep. 28, 2021
Debt interest rate			10.00%
Debt description			The conversion price is 60% multiplied by the lowest trading price for the common stock during the 20 trading day period ending on the latest complete trading day prior to the date of a conversion notice.
Purchase price			$ 100,000
Trading days | Trading			20
Debt interest rate increase/decrease			18.00%
Conversion price			0.60

Convertible Notes Payable - Sum

Convertible Notes Payable - Summary of Activity of Convertible Notes Payable and Convertible Debenture (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Beginning balance	$ 363,769	$ 34,065
Issuance of convertible debenture - principal amount	1,021,400	1,100,000
Issuance of convertible debenture - debt discount and original issue discount	(1,021,400)	(1,100,000)
Amortization of debt discount and original issue discount	862,209	368,257
Default penalty	530,134
Conversion to common stock, net of discount	(94,593)	(38,552)
Ending balance	1,661,520	363,769
Note [Member]
Beginning balance		34,065
Issuance of convertible debenture - principal amount
Issuance of convertible debenture - debt discount and original issue discount
Amortization of debt discount and original issue discount
Default penalty
Conversion to common stock, net of discount		(34,065)
Ending balance
Debenture [Member]
Beginning balance	363,769
Issuance of convertible debenture - principal amount	1,021,400	1,100,000
Issuance of convertible debenture - debt discount and original issue discount	(1,021,400)	(1,100,000)
Amortization of debt discount and original issue discount	862,209	368,257
Default penalty	530,134
Conversion to common stock, net of discount	(94,593)	(4,487)
Ending balance	$ 1,661,520	$ 363,769

Convertible Notes Payable - Sch

Convertible Notes Payable - Schedule of Balance Convertible Debenture Outstanding (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
Principal amount outstanding	$ 2,458,024
Less: Unamortized original issue discount	(94,857)
Less: Unamortized debt discount	(701,647)
Convertible note payable, net of debt discount	$ 1,661,520	$ 363,769	$ 34,065

Derivative Liability (Details N

Derivative Liability (Details Narrative) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Feb. 28, 2019	Dec. 31, 2018
Derivative liability	$ 1,930,235	$ 1,111,879		$ 42,104
2018 Note [Member]
Derivative liability			$ 42,104

Derivative Liability - Schedule

Derivative Liability - Schedule of Conversion Feature of Derivative Liability (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Risk-Free Interest Rate [Member]
Debt measurement input percentage	0.14
Risk-Free Interest Rate [Member] | Warrant [Member]
Debt measurement input percentage		2.11
Risk-Free Interest Rate [Member] | Tranche 1 [Member]
Debt measurement input percentage		2.11
Risk-Free Interest Rate [Member] | Tranche 2 [Member]
Debt measurement input percentage		1.75
Risk-Free Interest Rate [Member] | Tranche 3 [Member]
Debt measurement input percentage		1.67
Expected Term [Member]
Debt measurement input term	10 months 21 days
Expected Term [Member] | Warrant [Member]
Debt measurement input term		1 year 2 months 30 days
Expected Term [Member] | Tranche 1 [Member]
Debt measurement input term		1 year 2 months 30 days
Expected Term [Member] | Tranche 2 [Member]
Debt measurement input term		1 year 11 days
Expected Term [Member] | Tranche 3 [Member]
Debt measurement input term		10 months 21 days
Expected Volatility [Member]
Debt measurement input percentage	188.3
Expected Volatility [Member] | Warrant [Member]
Debt measurement input percentage		312.4
Expected Volatility [Member] | Tranche 1 [Member]
Debt measurement input percentage		312.4
Expected Volatility [Member] | Tranche 2 [Member]
Debt measurement input percentage		303.70
Expected Volatility [Member] | Tranche 3 [Member]
Debt measurement input percentage		326.88
Expected Dividend Yield [Member]
Debt measurement input percentage	0
Expected Dividend Yield [Member] | Warrant [Member]
Debt measurement input percentage		0
Expected Dividend Yield [Member] | Tranche 1 [Member]
Debt measurement input percentage		0
Expected Dividend Yield [Member] | Tranche 2 [Member]
Debt measurement input percentage		0
Expected Dividend Yield [Member] | Tranche 3 [Member]
Debt measurement input percentage		0
Exercise Price of Underlying Common Shares [Member]
Debt measurement input percentage	0.01
Exercise Price of Underlying Common Shares [Member] | Warrant [Member]
Debt measurement input percentage		0.08
Exercise Price of Underlying Common Shares [Member] | Tranche 1 [Member]
Debt measurement input percentage		0.09
Exercise Price of Underlying Common Shares [Member] | Tranche 2 [Member]
Debt measurement input percentage		0.04
Exercise Price of Underlying Common Shares [Member] | Tranche 3 [Member]
Debt measurement input percentage		0.04

Derivative Liability - Schedu_2

Derivative Liability - Schedule of Derivative Liability Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Beginning balance	$ 1,111,879	$ 42,104
Conversion of convertible notes payable to common stock		(737,813)
Initial fair value on issuance of convertible debenture	1,265,775	1,570,038
Debenture conversions	(247,209)
New warrant issuances	39,690
Common stock warrant exercises	(72,244)	(168,771)
Conversion of principal amount of debenture to common stock		(24,137)
Change in fair value of derivative liability	(265,742)	430,458
Ending balance	1,930,235	1,111,879
Debenture [Member]
Beginning balance	1,047,977	42,104
Conversion of convertible notes payable to common stock		(737,813)
Initial fair value on issuance of convertible debenture	1,265,775	1,077,117
Debenture conversions	(247,209)
New warrant issuances
Common stock warrant exercises
Conversion of principal amount of debenture to common stock		(24,137)
Change in fair value of derivative liability	(136,310)	690,707
Ending balance	1,930,235	1,047,977
Warrants [Member]
Beginning balance	63,902
Conversion of convertible notes payable to common stock
Initial fair value on issuance of convertible debenture		492,921
Debenture conversions
New warrant issuances	39,690
Common stock warrant exercises	(72,244)	(168,771)
Conversion of principal amount of debenture to common stock
Change in fair value of derivative liability	(31,348)	(260,249)
Ending balance		$ 63,902

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Details Narrative) - USD ($)	Jun. 04, 2019	Apr. 03, 2019	Mar. 29, 2019	Jan. 25, 2019	Jun. 30, 2020	May 31, 2020	Apr. 30, 2020	Mar. 31, 2020	Jan. 31, 2020	Oct. 31, 2019	Sep. 30, 2019	Apr. 30, 2019	Mar. 31, 2019	Feb. 28, 2019	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2019	Jun. 03, 2020	Mar. 26, 2020	Mar. 07, 2019
Common stock, shares authorized															2,000,000,000	2,000,000,000	2,000,000,000		500,000,000
Common stock, par value															$ 0.001	$ 0.001	$ 0.001		$ 0.001
Preferred stock, shares authorized															10,000,000	10,000,000	10,000,000		10,000,000
Preferred stock, par value															$ 0.001	$ 0.001	$ 0.001		$ 0.001
Number of shares of common stock													8,600,298
Share issued for services, value																	$ 7,500
Exercise of stock options																$ 10,400	5,000
Number of common stock warrants exercises																4,170,000
Number of stock issued upon conversion															49,110,845
Number of stock issued upon conversion, value															$ 171,600		46,048
Accrued salary and interest accruals																	$ 348,312
Debt conversion price per share																				$ 0.08
Series B Preferred Stock [Member]
Preferred stock, shares authorized		1,500,000													500,000	500,000	500,000
Preferred stock, par value		$ 0.001
Number of shares of common stock		125,000					958,333
Share issued for services, value
Common shares issued for services and compensation, shares
Conversion of Series B preferred stock for common shares							25,000									(25,000)	(50,000)
Number of options exercised
Exercise of stock options
Number of stock issued upon conversion
Number of stock issued upon conversion, value
Dividend stated value, price per share		$ 1.15
Redemption price per share		$ 1.35
Number of shares issued, value		$ 125,000
Conversion of stock amount converted		25,000
Investment recognized and amortized		28,750
Amortization expense																	$ 36,412
Conversion of stock description																	Subject to earlier conversion or redemption, the Series B Preferred Stock will automatically convert into fully paid and non-accessible shares of our common stock 24 months following the date of issuance of such Series B Preferred Stock without any action or payment required on the part of the holder of the Series B Convertible Preferred Stock. Subject to a floor price limitation of $0.03 per share, the automatic conversion price to which the Conversion/Dividend Stated Value will be applied will be the lower of (i) $0.10 per share of common stock; or (ii) a 20% discount to the lowest volume weighted average price ("VWAP") for our common stock on our principal trading market during the five (5) trading days immediately prior to the automatic conversion date.
Preferred stock, shares issued															50,000	50,000	75,000
Series B Dividends [Member]
Number of shares issued, value																$ 38,287
Accrued interest															$ 12,075	$ 12,075
Series C Preferred Stock [Member]
Preferred stock, shares authorized															129,559	129,559	129,559
Share issued for services, value
Common shares issued for services and compensation, shares
Conversion of Series B preferred stock for common shares
Number of options exercised
Exercise of stock options
Number of stock issued upon conversion
Number of stock issued upon conversion, value
Preferred stock, shares issued															129,559	129,559		129,559
Common Stock [Member]
Number of shares of common stock							90,216						8,600,298
Number of shares issued for services																	250,000
Share issued for services, value																	$ 250
Common shares issued for services and compensation, shares																16,279,273
Conversion of Series B preferred stock for common shares																958,333	1,465,949
Number of options exercised																4,000,000	500,000
Exercise of stock options																$ 4,000	$ 500
Number of stock issued upon conversion																	427,500
Number of stock issued upon conversion, value																	$ 428
Conversion of stock amount converted		28,750
Investment recognized and amortized		$ 25,000
Pride Partners LLC [Member]
Number of shares of common stock																	427,500
Pride Partners LLC [Member] | Warrant [Member]
Number of shares of common stock																	4,365,000
Securities Exchange Agreement [Member] | Common Stock [Member]
Number of shares issued for conversion	129,558,574
Securities Exchange Agreement [Member] | LGBT Loyalty LLC [Member]
Number of restricted common stock, shares				120,959,996
Common stock, issued and outstanding percentage				49.99%
Securities Exchange Agreement [Member] | Maxim Partners, LLC [Member]
Number of stock issued upon conversion			8,598,578
Number of stock issued upon conversion, value			$ 388,675
Employment Services Agreement [Member] | Series C Preferred Stock [Member]
Preferred stock, par value	$ 1,000
Conversion of stock description	Each share of Series C Preferred Stock is convertible, at any time and from time to time, at the option of the holder thereof, into that number of shares of Common Stock (subject in each case to a 4.99% beneficial ownership limitation) determined by dividing the Stated Value of such share of Series C Preferred Stock by the Series C Preferred Stock conversion price of $1.00 per share. Consequently, each Share of Series C Preferred Stock is presently convertible into 1,000 shares of Common Stock.
Number of shares issued for conversion	129,559
Debt conversion price per share	$ 1
Bridge Noteholder [Member]
Number of shares of common stock									294,994
Consultant [Member]
Number of shares of common stock														250,000
Number of shares issued for services																10,052,318
Share issued for services, value														$ 7,500		$ 459,417
Number of options exercised														500,000
Exercise of stock options														$ 5,000
Consultant [Member] | Restricted Common Stock [Member]
Number of shares issued for services														750,000
Durwood Orlando Reece [Member]
Number of shares of common stock								1,000,000
Common shares issued for services and compensation, shares						11,942,161
Executive Officers [Member]
Number of shares issued for services						12,889,267
Share issued for services, value						$ 139,215
Option Holders [Member]
Number of options exercised					4,000,000
Stock options exercised price					$ 0.0026
Exercise of stock options					$ 10,400
Two Lender [Member]
Number of shares of common stock																	26,586,234
Five Unrelated Individuals [Member]
Number of shares of common stock												5,000,000	5,000,000				5,000,000
Investor [Member] | Series B Preferred Stock [Member]
Number of stock issued upon conversion, value																	$ 50,000
Investor [Member] | Common Stock [Member]
Number of shares of common stock																	38,827
Investor [Member] | Two Series B Preferred Stock [Member]
Number of shares of common stock																	1,465,949
Series B Investor [Member] | Series B Preferred Stock [Member]
Conversion of stock shares converted										25,000	25,000
Series B Investor [Member] | Common Stock [Member]
Conversion of stock shares converted										731,031	734,918
Deferred Officer Compensation [Member]
Amortization of deferred officer compensation																	$ 195,054

Options and Warrants (Details N

Options and Warrants (Details Narrative) - USD ($)	Dec. 13, 2019	Jun. 04, 2019	Jan. 25, 2019	May 31, 2020	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Oct. 31, 2020	Aug. 31, 2020	Dec. 31, 2018
Stock based compensation expense
Number of warrants exercised						4,170,000
Grant and exercise of warrants						2,285,000
Proceeds from warrant exercises						$ 93,342	$ 137,524
Shares of common stock					8,600,298
Warrant [Member]
Number of warrants exercised							4,365,000
Grant and exercise of warrants						238,118,333	21,850,298
Proceeds from warrant exercises							$ 137,524
Warrants to purchase common stock		6,250,000
Warrants exercise price description		The exercise price per share of common stock under this warrant shall be the lesser of (i) $0.0855, or (ii) 75% of the lowest single trading day closing price during the five trading days prior to the exercise date.
Exercise price of warrants		$ 0.0855
Auctus Note [Member] | Warrant [Member]
Warrants to purchase common stock								200,000,000	7,500,000
Exercise price of warrants								$ 0.15	$ 0.15
EMA Note [Member] | Warrant [Member]
Warrants to purchase common stock								28,333,333
Exercise price of warrants								$ 0.15
Board Members [Member]
Number of warrants cancelled				7,000,000
Board Members [Member] | Warrant [Member]
Number of warrants exercised	7,000,000
Exercise price of warrants	$ 0.03
Two Company Executives [Member]
Warrants issued in exchange for cancellation of salary and interest accruals			$ 348,312
2012 Equity Incentive Plan [Member]
Options outstanding						1,800,000	5,800,000			6,300,000

Options and Warrants - Schedule

Options and Warrants - Schedule of Stock Options (Details) - 2012 Equity Incentive Plan [Member] - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Options Outstanding, Beginning	5,800,000	6,300,000
Options Outstanding, Granted
Options Outstanding, Exercised	(4,000,000)	(500,000)
Options Outstanding, Forfeited
Options Outstanding, Ending	1,800,000	5,800,000
Options Exercisable, Ending	1,800,000
Weighted Average Exercise Price Outstanding, Beginning	$ 0	$ 0.0049
Weighted Average Exercise Price Granted
Weighted Average Exercise Price Exercised	0.01	0.01
Weighted Average Exercise Price Forfeited
Weighted Average Exercise Price Outstanding, Ending	0	$ 0
Weighted Average Exercise Price Exercisable, Ending	$ 0.0045
Weighted Average Remaining Contractual Term (in years) Outstanding, Beginning	1 year 6 months	2 years 4 months 24 days
Weighted Average Remaining Contractual Term (in years) Outstanding, Ending	6 months	1 year 6 months
Weighted Average Remaining Contractual Term (in years) Exercisable, Ending	6 months
Aggregate Intrinsic Value Outstanding, Beginning
Aggregate Intrinsic Value Granted
Aggregate Intrinsic Value Exercised
Aggregate Intrinsic Value Forfeited
Aggregate Intrinsic Value Outstanding, Ending
Aggregate Intrinsic Value Exercisable, Ending

Options and Warrants - Summary

Options and Warrants - Summary of Warrant Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Warrants, Granted	2,285,000
Warrant [Member]
Warrants Outstanding beginning balance	8,885,000
Warrants, Granted	238,118,333	21,850,298
Warrants, Exercised	(4,170,000)	(12,965,298)
Warrants, Forfeited	(7,000,000)
Warrants Outstanding ending balance	235,833,333	8,885,000
Weighted Average Exercise Price beginning balance	$ 0.04
Weighted Average Exercise Price, Granted	0.02	0.05
Weighted Average Exercise Price, Exercised	0.08	0.05
Weighted Average Exercise Price, Forfeited	0.03
Weighted Average Exercise Price ending balance	$ 0.02	$ 0.04

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	1 Months Ended				12 Months Ended
	May 31, 2020	Mar. 31, 2020	Apr. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Notes payable to related party					$ 17,885	$ 17,885
Debt instrument interest rate					2.00%	2.00%
Number of shares of common stock				8,600,298
Accrued salaries							$ 348,312
Common shares issued to board of directors					$ 232,394	$ 555,400
Stock compensation expense					213,276	786,954
Accrued directors' compensation					94,584	80,000
Other receivables related parties					100,000	100,000
Accounts payable to related parties including officers and board members					18,981
Officers and Executive Director [Member]
Accrued salaries					299,732	$ 91,352
Board of Directors [Member]
Common shares issued to board of directors, shares	3,942,161
Common shares issued for services and compensation, shares	11,942,161
Annual compenation shares	8,000,000
Number of warrants cancelled	7,000,000
Shares issued and warrant modification	$ 214,595
Board of Directors [Member] | Orlando Reece [Member]
Common shares issued to board of directors, shares		1,000,000
Common shares issued to board of directors		$ 17,800
Five Unrelated Individuals [Member]
Number of shares of common stock			5,000,000	5,000,000		5,000,000
Stock compensation expense			$ 555,401	$ 555,401
Five Individuals [Member]
Accrued directors' compensation					$ 25,000

Income Taxes (Details Narrative

Income Taxes (Details Narrative)	12 Months Ended
	Dec. 31, 2020USD ($)
Income Tax Disclosure [Abstract]
Deferred tax benefit, reserve	100.00%
Deferred tax benefit	$ 1,332,000
Net operating loss carry forwards	$ 6,539,000

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Tax Provision Benefit (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Federal
State
Total current income tax provision
Federal	(139,793)	(497,200)
State	(36,607)	(130,200)
Total deferred income tax benefit	(176,400)	(627,400)
Change in deferred tax asset valuation allowance	176,400	627,400
Total provision for income taxes

Income Taxes - Schedule of Sour

Income Taxes - Schedule of Sources and Tax Effects (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Federal statutory income tax rate	21.00%	21.00%
State income taxes, net of federal benefit	5.50%	5.50%
Change in deferred tax asset valuation allowance	(26.50%)	(26.50%)
Effective income tax rate	0.00%	0.00%

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Deferred Income Tax Assets (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$ 1,363,000	$ 1,155,600
Depreciation and amortization	(31,000)
Valuation allowance	(1,332,000)	(155,600)	$ (528,200)
Net deferred tax assets

Income Taxes - Schedule of Valu

Income Taxes - Schedule of Valuation Allowance (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Valuation allowance as of beginning of year	$ 155,600	$ 528,200
Increases recorded to income tax provision	176,400	627,400
Valuation allowance as of end of year	$ 1,332,000	$ 155,600

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - Employment Services Agreements [Member] - USD ($)	Jan. 02, 2020	Dec. 19, 2017
Officer's compensation		$ 150,000
Officer's salary	$ 200,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Apr. 08, 2021	Mar. 05, 2021	Apr. 30, 2021	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2019	Feb. 05, 2021	Feb. 04, 2021	Mar. 26, 2020
Common stock, shares authorized					2,000,000,000	2,000,000,000	2,000,000,000			500,000,000
Common stock, par value					$ 0.001	$ 0.001	$ 0.001			$ 0.001
Debt interest rate					2.00%	2.00%	2.00%
Principal amount					$ 2,458,024	$ 2,458,024
Number of stock issued upon conversion					49,110,845
Preferred stock, par value					$ 0.001	$ 0.001	$ 0.001			$ 0.001
Preferred stock, shares authorized					10,000,000	10,000,000	10,000,000			10,000,000
Number of shares issued				8,600,298
Net proceeds for preferred stock							$ 125,000
Series D Preferred Stock [Member]
Number of stock issued upon conversion
Preferred stock, shares authorized					400	400	400
Subsequent Event [Member]
Common stock, shares authorized								2,000,000,000	1,000,000,000
Common stock, par value								$ 0.001	$ 0.001
Subsequent Event [Member] | Series D Convertible Preferred Stock [Member]
Preferred stock, par value			$ 0.001
Subsequent Event [Member] | Series D Preferred Stock [Member]
Preferred stock, par value			$ 1,200
Preferred stock, shares authorized			400
Preferred stock dividend percentage			8.00%
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Series D Preferred Stock [Member] | GHS Investments, LLC [Member]
Number of shares issued	400
Net proceeds for preferred stock	$ 427,600
Warrants to purchase of shares	40,000,000
Warrant exercise price	$ 0.001
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Power Up 2021 Note [Member]
Purchase price		$ 78,500
Debt interest rate		10.00%
Principal amount		$ 86,350
Debt maturity date		Mar. 5, 2022
Debt conversion, description		The "Variable Conversion Price" shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date.
Number of stock issued upon conversion		37,538,998